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Abstract
Objectives: Medical treatment is generally advocated for patients with acute type B aortic dissection without complications. The objective
of this retrospective analysis was to determine whether there are any initial findings that can help predict the long-term course of the disease.
Methods: Case records of the 130 patients treated for type B aortic dissection between 1988 and 1997 were reviewed; 41 (31%) were
operated on in the acute phase (,14 days), 31 (24%) were operated on in the chronic phase and 58 (45%) were treated medically. Results:
Overall acute mortality was 10.8%; 22% for patients operated on in the early phase and 5.6% for medically treated patients. Age ðP ¼ 0:002Þ,
persistent pain ðP ¼ 0:01Þ and malperfusion ðP ¼ 0:001Þ were significant independent predictors of the need for surgery. Paraplegia/para
paresis ðP ¼ 0:0001Þ, leg ischaemia ðP ¼ 0:003Þ, pleural effusion ðP ¼ 0:003Þ, rupture ðP ¼ 0:0001Þ, shock ðP ¼ 0:0001Þ, age ðP ¼ 0:003Þ,
cardiac failure ðP ¼ 0:002Þ and aortic diameter .4.5 cm ðP ¼ 0:002Þ were significant predictors of poor survival. Age and shock also
emerged as independent risk factors. Patients without malperfusion ðP ¼ 0:0001Þ, pleural effusion ðP ¼ 0:003Þ, rupture ðP ¼ 0:0001Þ and
shock ðP ¼ 0:0001Þ had a significantly better event-free survival (freedom from repeat surgery and death). The actuarial survival rate for
high-risk patients (malperfusion, rupture, shock) was 62% at 1 year and 40% at 5 years; the corresponding values for low-risk patients were
94 and 84%, respectively. Conclusions: Rupture, shock and malperfusion are significant predictors of poor survival in patients with acute
type B aortic dissection. q 2002 Published by Elsevier Science B.V.
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1. Introduction
Dissection is the most common catastrophic event that
affects the thoracic and abdominal aorta. Unfortunately, it
also remains one of the most challenging disorders facing
the cardiovascular surgeon. There is still some controversy
concerning the therapeutic strategies for patients with type
B aortic dissection [1]. The gradual improvement in recent
years of outcome after surgery for acute dissection of the
aorta has resulted in a consensus favouring operative inter-
vention for almost all type A dissections and an increasing
number of type B dissections. Although most surgeons now
agree that immediate surgery is appropriate for acute type B
dissection if there is intractable pain, uncontrollable hyper-
tension or serious organ malperfusion [2], medical treatment
with a beta blocker is generally advocated for patients with-
out complications [3]. One important question, however, is
whether any predictors of negative survival of a patient with
type B aortic dissection already exist at the time of initial
hospitalisation.
2. Materials and methods
Between 1988 and 1997, 130 patients were treated for type
B aortic dissection at the University Hospital Zurich. Of
these, 26 (20%) were females and 104 (80%) were males.
The mean (^SD) age at the time of hospitalisation was
61:0 ^ 11:2 years (range 23–84 years); 80 patients (61.5%)
were more than 60 years old and 31 (23.8%) were more than
70 years old. Symptoms and clinical findings at the time of
hospitalisation are listed in Table 1. The patients were also
suffering from the following conditions: hypertension
(81.5%), coronary artery disease (23.8%), gastrointestinal
disease (16.9%), previous aortic surgery (13.8%), renal
insufficiency (11.5%), chronic obstructive pulmonary
disease (10.8%), heart failure (5.4%), previous neurological
event (3.8%), diabetes mellitus (3.1%) or others (26.2%).
The diameter of the aorta at the time of diagnosis was
,3.4 cm in 16.1%, 3.5–4.4 cm in 33.9%, 4.5–5.4 cm in
27.4%, 5.5–6.4 cm in 11.3% and .6.5 cm in 11.3%.
European Journal of Cardio-thoracic Surgery 22 (2002) 59–63
1010-7940/02/$ - see front matter q 2002 Published by Elsevier Science B.V.
PII: S1010-7940(02)00203-8
www.elsevier.com/locate/ejcts
* Corresponding author. Division of Cardiac Surgery, Triemli Hospital,
8063 Zurich, Switzerland. Tel.: 141-1-466-1111; fax: 141-1-466-2745.
E-mail address: michele.genoni@triemli.stzh.ch (M. Genoni).
Fifty-two of the 130 patients (40%) were treated surgically
at first hospitalisation (Fig. 1), 41 as emergency cases during
the acute phase (,14 days after onset of symptoms) and 11 as
urgent cases before discharge. The most frequent indications
for emergency surgery were malperfusion (34%) (presenting
as leg ischaemia in eight patients and visceral ischaemia in
six patients, five of them with renal ischaemia and one with
ischaemia of the coeliac axis), potential rupture (27%)
(presenting as pleural effusion in eight patients and large
(.6 cm) aortic diameter in three patients) and aortic rupture
(19%). Indications for urgent surgery, i.e. before discharge
from the first hospitalisation, were malperfusion (36%), left
pleural effusion (18%), increasing aortic diameter (18%),
persistent pain (9%) and other indications (19%).
In the absence of rupture or complications of the aortic
dissection, the remaining 78 patients (60%) were primarily
treated medically. The mean (^SD) age of the medically
treated patients was 64:0 ^ 12:3 years. As previously
recommended [3], the majority of these patients (51/78;
65.4%) received treatment with beta blockers.
The records of all patients who were treated for type B
aortic dissection were reviewed. Those patients who were
still alive were contacted and asked to complete a question-
naire with the help of their doctor; particular attention was
focused on collecting CT scan data. The total follow-up
period encompassed 194 years, with a mean observation
time of 4:2 ^ 2:2 years. The in-hospital mortality rate was
14.6% (19/130) and, of the remaining 111 patients, follow-
up was completed in 105 (95%). A total of 37 patients died
during follow-up.
In order to determine any predictors affecting survival
rate and survival rate free from any event (death and
surgery, respectively) and/or influencing the indication for
surgery, the following variables were analysed: persistent
pain, paraplegia/para paresis, malperfusion, leg ischaemia,
visceral ischaemia, persistent hypertension, pleural effusion,
rupture, shock, aortic diameter at hospitalisation, poor left
ventricular ejection fraction, cardiac failure, coronary artery
disease, known hypertension, diabetes mellitus, arterio-
sclerosis, previous aortic surgery, pre-existing neurological,
intestinal, renal or pulmonary disease, localisation of the
dissection and the condition of the false lumen.
2.1. Statistical analyses
Variables were reported either as a percentage or mean ^
standard deviation. Statistical analyses were performed
using SPSS 6.1 software. Nominal variables were evaluated
using the Chi-quadrant test and independent variables using
the Mann–Whitney and Kruskal–Wallis test; univariate
analyses were performed on continuous variables using
the Wilcoxon-signed rank test. Differences between groups
were analysed using the log–rank test. Significance was
assumed at a P level of ,0.05.
3. Results
The overall mortality rate in the acute phase was 10.8%
(14/130); 5.6% (5/89) of patients who had until then only
received medical treatment and 22% (9/41) of patients oper-
ated on in this phase (i.e. emergency surgery). The in-hospital
mortality rate was 9% (7/78) for the medically treated
patients, compared with 9.1% (1/11) for patients undergoing
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Table 1
Symptoms and clinical findings at hospitalisation in relation to acute and in-hospital mortality rate
Number of patients Acute mortality N (%) In-hospital mortality N (%)
Pleural effusion 44 8 (18%) 12 (27%)
Visceral ischaemia 24 0 3 (12.5%)
Aortic wall haematoma 20 2 (10%) 3 (15%)
Leg ischaemia 19 6 (32%) 6 (32%)
Persistent pain 17 0 0
Rupture 15 8 (53%) 9 (60%)
Aortic diameter progression 7 1 (14%) 1 (14%)
Shock 6 4 (67%) 6 (100%)
Resistant blood pressure 3 0 0
Para paresis 3 1 (33%) 1 (33%)
Paraplegia 2 2 (100%) 2 (100%)
Fistula 1 0 1 (100%)
Fig. 1. Therapeutic strategies in the treatment of acute type B aortic dissec-
tion.
urgent surgery and 27% (11/41) for those undergoing emer-
gency surgery. A total of 111/130 patients were discharged
alive.
The symptoms and clinical findings that resulted in hospi-
talisation are shown in Table 1. Pain is the most important
symptom of a type B aortic dissection, although it persisted in
only 13% of the patients at hospitalisation. For acute mortal-
ity, the single symptoms/clinical findings associated with the
highest mortality rates were paraplegia (100% mortality
rate), shock (67%), rupture (53%) and leg ischaemia
(33%). In-hospital mortality was highest for patients with
paraplegia, shock, rupture, para paresis and leg ischaemia.
Twenty patients had surgery after discharge from their
first hospitalisation. The main reason for surgical interven-
tion was an increase of the diameter of the aorta (14/20),
followed by visceral ischaemia (2/20), persistent pain (2/
20), leg ischaemia (1/20) and possible rupture (1/20). The
initial findings in this group of patients were large aortic
diameter (8/20), haematoma of the aorta (3/20), leg ischae-
mia (3/20), persistent pain (2/20), visceral ischaemia (2/20),
resistant blood pressure (1/20) and pleural effusion (1/20).
Sixteen patients required a repeat of their surgery during the
follow-up period; initial findings in this group included
pleural effusion .300 ml on the left side (6), visceral
ischaemia (5), persistent pain (4), leg ischaemia (2), resis-
tant blood pressure (1) and haematoma of the aortic wall (1).
As shown in Table 2, age ðP ¼ 0:002Þ, persistent pain
ðP ¼ 0:01Þ, malperfusion ðP ¼ 0:008Þ, leg ischaemia ðP ¼
0:0001Þ and rupture ðP , 0:0001Þ significantly influenced
the necessity for initial surgery. Age, persistent pain and
malperfusion were also independent factors. Pre-operative
paraplegia/para paresis ðP ¼ 0:0001Þ, leg ischaemia
ðP ¼ 0:003Þ, pleural effusion ðP ¼ 0:003Þ, rupture
ðP ¼ 0:0001Þ, shock ðP ¼ 0:00001Þ, age ðP ¼ 0:003Þ,
cardiac failure ðP ¼ 0:002Þ and aortic diameter .4.5 cm
ðP ¼ 0:002Þ had a significant negative effect on survival
rate (Table 3). Age and shock were also independent factors.
For those patients who were treated primarily with surgery,
rupture ðP ¼ 0:006Þ and pleural effusion ðP ¼ 0:02Þ are the
only factors that had a significant negative effect on survival
rate. Rupture was the single independent factor in these
patients. Amongst patients who were treated medically,
age ðP ¼ 0:006Þ, gender ðP ¼ 0:009Þ, malperfusion
ðP ¼ 0:008Þ, leg ischaemia ðP ¼ 0:0003Þ, pleural effusion
ðP ¼ 0:0007Þ, rupture ðP , 0:0001Þ, shock ðP , 0:0001Þ,
cardiac failure ðP ¼ 0:002Þ and aortic diameter .4.5 cm
ðP ¼ 0:002Þ were all factors that had a significant negative
effect on survival rate. There were no independent factors in
this group of patients. The actuarial survival rate for high-
risk patients (malperfusion, rupture, shock) was 62% at 1
year and 40% at 5 years. The corresponding values for low-
risk patients were 94 and 84%, respectively. Predisposing
disease does not influence actuarial survival.
Malperfusion ðP ¼ 0:0002Þ, leg ischaemia ðP ¼ 0:0001Þ,
pleural effusion ðP ¼ 0:003Þ, rupture ðP , 0:0001Þ, shock
ðP , 0:0001Þ, hypertension ðP ¼ 0:004Þ and aortic
diameter .4.5 cm ðP ¼ 0:008Þ had a significant negative
effect on survival rate free from any event. Shock was the
only independent factor.
Fig. 2 shows survival curve reflecting freedom from any
event for high- and low-risk patients surviving the first 30
days.
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Table 2
Factors significantly affecting necessity for surgerya
Factor P value
Age 0.002
Persistent pain 0.01
Malperfusion 0.008
Leg ischaemia 0.0001
Rupture ,0.0001
a Note: age, pain and malperfusion are also independent factors.
Table 3
Factors with a significant negative effect on survival ratea
Factor P value
Paraplegia/para paresis 0.0001
Leg ischaemia 0.003
Pleural effusion 0.003
Rupture 0.0001
Shock 0.00001
Age 0.003
Cardiac failure 0.002
Aortic diameter .4.5 cm 0.002
a Note: age and shock are also independent factors.
Fig. 2. Actuarial survival curve reflecting freedom from any event for high-
risk and low-risk patients.
4. Discussion
Specific initial findings that are indications for emergency
surgery (rupture, shock, organ ischaemia) negatively affect
the course of type B aortic dissection. It has been generally
advocated that patients who have type B acute aortic dissec-
tion without complications, such as rupture, potential
rupture or organ ischaemia, should be treated with hypoten-
sive drugs during the acute phase and that surgical treatment
be carried out if the aortic diameter becomes enlarged
during the chronic phase. However, there is some contro-
versy concerning patients with type B aortic dissection.
Higher early mortality with surgical treatment than with
medical treatment, higher operative mortality in the acute
phase than in the chronic phase and higher late mortality in
patients treated only medically than in those treated surgi-
cally have all been recognised in many institutions [1,4,5].
In our experience, uncomplicated dissections are not an
indication for surgery. The survival rate of patients treated
medically in the acute phase can be improved significantly by
long-term beta-blocker treatment [3]. The higher mortality
rate in the acute phase of type B aortic dissection, when
surgical treatment is inevitable due to the previously
discussed clinical findings, as well as the in-hospital mortal-
ity of type B acute aortic dissection, underline the diversity of
the two patient groups regarding their risk profile. In contrast
to the medically treated patients, surgical patients are, in
general, those who have the factors that negatively affect
survival rate. In fact, in our patient series, indications for
emergency surgery were malperfusion in 34%, potential
rupture in 27% and rupture in 19%. In addition to these
factors, age also has a statistically significant effect on survi-
val rate. The higher mortality rate in the acute phase was due
to patients with rupture (mortality rate 53.3%) and malperfu-
sion (mortality rate 19%). Together with shock and paraple-
gia, these two clinical findings have the highest mortality rate
in the acute phase. Therefore, compared with medically trea-
ted patients, surgical patients are at high risk and it would be
an error to compare the survival of these two patient groups.
Although a diagnosis of rupture is clinically clear in the
majority of cases, diagnoses of malperfusion of the truncus
coelicaus, mesenterial and renal arteries in patients with
type B aortic dissection is extremely difficult despite the
fact that malperfusion occurs in up to 30% of patients
with an aortic dissection [6–8]. In agreement with Webb
and Williams [6], we hypothesise that re-entry, either spon-
taneous or surgical, is essential to prevent malperfusion in
type B aortic dissection. In some cases, atypical abdominal
pain may be the only sign of a malperfusion. A suspected
diagnosis of malperfusion is therefore frequently only given
when minimal clinical signs, such as abdominal tension,
increasing metabolic acidosis, progressive elevation of
liver enzymes and uncontrollable hypertension as a sign
of decreased renal perfusion, persist [9]. The difficult and
late diagnosis of visceral malperfusion is one of the reasons
why a large proportion of our patients are not operated on in
the acute phase (2 weeks from diagnosis) and why the
mortality rate is also increased after this time. When malper-
fusion is suspected, aggressive clinical, laboratory and radi-
ological assessment is recommended.
In agreement with Carrel et al. [10], rupture and malper-
fusion do not appear to be the only factors that negatively
affect the survival rate at the time of diagnosis of type B
aortic dissection. These other factors include pre-existing
cardiac failure or pre-operative paraplegia, pleural effusion
and the aortic diameter. However, in contrast, Juvonen et al.
[11] reported that aneurysm size, as defined by a variety of
dimensional variables including maximal diameter in the
descending thoracic aorta, is apparently not a significant
predisposing factor for rupture. Nevertheless, both pleural
effusion and enlarged aortic diameter are clinical findings
that are associated with potential rupture.
Enlarged aortic diameter was also found to be a predictor
of worse course in the whole group of patients and in the
group who were primarily medically treated; pleural effu-
sion was also a predictor in surgically treated patients. The
risk of rupture, which is usually fatal, must, however, be
balanced against the not inconsiderable morbidity and
mortality associated with elective surgery [12]. Calculation
of rupture risk for a patient with chronic type B dissection
according to the formula developed for patients with non-
dissecting aneurysms would be likely to somewhat under-
estimate the risk for rupture, although it might nevertheless
be helpful in trying to determine which individual patients
are most vulnerable [11]. For these patients with pleural
effusion and/or enlarged aortic diameter, the risk of elective
surgery for chronic type B dissection is warranted because
rupture is imminent. It is important not to forget, however,
the favourable effect of beta blockers in preventing enlarge-
ment of the diseased aorta and in increasing survival of
chronic type B aortic dissection [3]. Nevertheless, the ther-
apeutic strategies for type B aortic dissection have changed
in the previous years, particularly for malperfusion and the
locally enlarged aorta, where new interventional methods
with fenestration and endoaortic prosthesis show promising
results [13,14].
References
[1] Neya K, Omoto R, Kyo S, Kimura S, Yokoto Y, Takamoto S, Adachi
H. Outcome of Stanford type B acute aortic dissection. Circulation
1992;86(Suppl II):1–7.
[2] Elefteriades JA, Hartleroad J, Gusberg RJ, Salazar AM, Black HR,
Kopf GS, Baldwin JC, Hammond GL. Long term experience with
descending aortic dissection: the complication-specific approach.
Ann Thorac Surg 1992;53:11–21.
[3] Genoni M, Paul M, Jenni R, Graves K, Seifert B, Turina M. Chronic
beta-blocker therapy improves outcome and reduces treatment costs
in chronic type B aortic dissection. Eur J Cardiothorac Surg
2001;19:606–610.
[4] Appelbaum A, Karp RB, Kirklin JW. Ascending versus descending
aortic dissection. Ann Surg 1976;183:296–300.
[5] Wheat MW. Acute dissecting aneurysms of the aorta: diagnosis and
treatment. Am Heart J 1980;99:372–387.
M. Genoni et al. / European Journal of Cardio-thoracic Surgery 22 (2002) 59–6362
[6] Webb T, Williams GM. Abdominal aortic tailoring for renal, visceral,
and lower extremity malperfusion resulting from acute aortic dissec-
tion. J Vasc Surg 1997;26:474–480 (see also Discussion p. 480–1).
[7] Fann J, Smith J, Miller D, Mitchell R, Moore K, Grunkemeir G,
Stinson E, Oyer P, Reitz B, Shumway N. Surgical management of
aortic dissection during a 30-year period. Circulation 1995;92(Suppl
9):113–121.
[8] Slonim S, Nymann U, Semba C, Miller D, Mitchell R, Dake M. Aortic
dissection: percutaneous management of ischaemic complications
with endovascular stents and balloon fenestration. J Vasc Surg
1996;23:241–253.
[9] Gysi J, Schaffner T, Mohasci P, Aeschbacher B, Althaus U, Carrel T.
Early and late outcome of operated and non-operated acute dissection
of the descending aorta. Eur J Cardiothorac Surg 1997;11:1163–1170.
[10] Carrel T, Nguyen T, Gysi J, Kipfer B, Sigurdsson G, Schafner T,
Schu¨pbach P, Althaus U. Akute Aortendissektion Typ B: prognose
nach initial konservativer Behandlung und pra¨diktive Faktoren fu¨r
einen komplizierten Verlauf. Schweiz Med Wochenschr
1997;127:1467–1473.
[11] Juvonen T, Ergin MA, Galla JD, Lansman SL, Nguyen KH, McCul-
lough JN, Levy D, de Asla RA, Bodian CA, Griepp RB. Prospective
study of the natural history of thoracic aneurysm. Ann Thorac Surg
1997;60:1533–1545.
[12] Juvonen T, Ergin MA, Galla JD, Lansmanm SL, McCullough JN,
Nguyen K, Bodian CA, Ehrlich MP, Spielvogel D, Klein JJ, Griepp
RB. Risk factors for rupture of chronic type B dissections. J Thorac
Cardiovasc Surg 1999;117:776–786.
[13] Tiesenhausen K, Amann W, Koch G, Hausegger KA, Oberwalder P,
Rigler B. Endovascular stent-graft repair of acute thoracic aortic
dissection-early clinical experiences. Thorac Cardiovasc Surg
2001;49:16–20.
[14] Bortone AS, Schema S, Mannatrizio G, Paradiso V, Ferlan G, Dialetto
G, Cotrufo M, de Luca Tupputi Schinosa L. Endovascular stent-graft
treatment for sieases of the descending thoracic aorta. Eur J Cardi-
othorac Surg 2001;20:514–519.
Appendix A. Conference discussion
Dr D. Dougenis (Patras, Greece): I would like you to elaborate a bit on
the role of the increased diameter of 4.5 in Type B dissection. Was that an
independent parameter in your multivariate analysis? Would you operate on
Type B dissection based only on the fact that the descending thoracic aorta
is more than 4.5 cm in diameter?
Dr Genoni: I think our problem is that the patients with acute Type B
aortic dissection are not in a surgical ICU in their initial hospitalisation,
they are in a medical intensive care unit, and so we must ask our colleagues
to call us for a decision of the therapeutic strategies. When the diameter is
enlarged and the patient is stable, we do not operate on the patient in the
very acute phase, but I think we have to treat him in the initial hospitalisa-
tion. We saw in our follow-up that the patients who need surgery in the
follow-up time for a large aortic diameter are patients who have an enlarged
aortic diameter at hospitalisation.
Dr E. Baudet (Bordeaux, France): Do you think that the introduction of a
stent graft could lead to reconsider the management of this Type B dissec-
tion for an early aggressive approach?
Dr Genoni: It depends on the symptoms of the patients. If the patients
have a malperfusion, I think the surgical treatment is not necessary. Then
we have the interventional treatment with stents, with fenestration. But in
patients with an enlarged aortic diameter, then the results in our hands of
stents are not very good. So we do make surgery in these cases.
Dr Baudet: Even if this minimal management is performed very early at
the time when the aorta is not too much enlarged?
Dr Genoni: It is very difficult because we have two problems. The first is
we have not only one entry, and we cannot see where the entry is, and the
second problem we have is the peripheral malperfusion after this technique.
Dr A. Haverich (Hannover, Germany): The primary referral unit is
probably cardiology or internal medicine. Do they refuse patients from
being admitted if there is a call from the outside hospital and there is a
clear diagnosis of acute Type B dissection? This is important because of the
epidemiology of the disease. In our unit, we would not accept patients
without enlargement, without complications. We would let them be treated
outside their own unit.
Dr Genoni: No. They accept the patients, make all initial diagnoses, and
then we want to discuss together the therapeutic strategy. After that, the
patients go back in the referring hospital.
Dr Haverich: A short question regarding your statistics. There were 65%
treated medically, 32% emergency operation and 9% were urgent. That
makes more than 100. Was there a crossover between the medical and
the surgical?
Dr Genoni: Yes. In the follow-up time we have not a crossover, but in the
initial are only patients in the first phase, and when one patient has been
operated, then he is in the surgical group.
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